Skip to Main Content

Category Archives: Non-Communicable Diseases

02.07.20

What does the Super Bowl have to do with Noncommunicable Diseases?

By Margherita Cinà

Last Sunday, I participated for the first time* in the great American tradition of watching the Super Bowl. During my emersion into this experience, I learned that every year, Super Bowl Nation awaits in anticipation for the commercials: they seem to be almost as important as the game itself! This year’s commercials, which reached on […]

Tags:
Thematic Areas: Non-Communicable Diseases

12.16.19

Let’s not forget that e-cigarettes are technically illegal in the U.S. right now

By Darlene Huang

Last week, the U.S. Court of Appeals for the D.C. Circuit issued its decision in Nicopure Labs, LLC v. FDA. Finding fully in favor of the FDA, the court affirmed the district court’s judgement upholding the Tobacco Control Act (TCA) and its application to e-cigarettes. The litigation stemmed from FDA’s May 2016 “deeming rule” making […]

Thematic Areas:

11.07.19

All eyes on menthol

By Darlene Huang

As if the e-cigarette saga weren’t dramatic enough, Juul announced today that it will only sell its tobacco- and menthol-flavored products in the U.S. now. This comes before the current Administration’s announcement of a new flavored e-cigarette policy by the U.S. Food and Drug Administration (FDA), which is expected any day now, and is the […]

10.18.19

Utilizing Model Laws to Expand Access to Cancer Treatments in Africa

By Lidiya Teklemariam

WHO reports that 70% of deaths caused by cancer occur in low and middle-income countries where it is very difficult to access diagnosis and treatment leading to late-stage identification of the disease and minimal chance of survival. One of the things that come to my mind when I think of Africa and cancer is the […]

Tags:

09.26.19

See the forest for the trees: the short-sightedness of a singular focus on e-cigarettes

By Darlene Huang

The 2019 lunar new year was supposed to be an unlucky year for me based on Chinese astrology. I don’t usually give much weight to these horoscope-like predictions, but my awareness was heightened this year with my own wedding taking place earlier this month. Thankfully, it was a beautiful day, and I can report no […]

07.11.19

What I wish I knew 15 years ago about American Spirits cigarettes

By Darlene Huang

I used to wait tables. I started as a teen at my family’s restaurants before smoke-free workplace laws swept the nation. Like most restaurants at the time, we had a smoking section, and I oftentimes was assigned to it. I was thrilled when the city eventually adopted a clean indoor air ordinance, and a few […]

05.15.19

A tale of two sentiments two weeks after FDA permits the sale of IQOS

By Darlene Huang

It’s been just over two weeks since the U.S. Food and Drug Administration (FDA) authorized the sale of Philip Morris’ IQOS heated tobacco product (HTP) system in regular tobacco and menthol flavors. It’s also been exactly two years since the premarket tobacco product application (PMTA) for this product that creates an aerosol (not smoke) from […]

04.04.19

Reflecting on progress made in tobacco and nicotine products regulation under FDA Commissioner Gottlieb

By Darlene Huang

Tomorrow is Commissioner Gottlieb’s last day on the job at the U.S. Food and Drug Administration (FDA), and he’s been treating these last few days much like he has his entire two-year tenure: with carefully thought out and coordinated communication about both in-process and potential future FDA actions. While the agency has been hard at […]

02.11.19

Reality check: Cigarettes are the only reason reduced risk tobacco products are even a thing

By Darlene Huang

First, a confession. I’m a total public health nerd. I’ve been absolutely captivated by the prevention of disease at a population level since I was introduced to the concept late in college. From the science that drives it to the programs, policies, and laws that either embrace or hinder it and everything in between and […]

Thematic Areas:

The views reflected in this blog are those of the individual authors and do not necessarily represent those of the O’Neill Institute for National and Global Health Law or Georgetown University. This blog is solely informational in nature, and not intended as a substitute for competent legal advice from a licensed and retained attorney in your state or country.

See the full disclaimer and terms of use.